![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
News
FDA Approves Basaglar® (insulin glargine injection), a Long-Acting Insulin Treatment
Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc announced that the U.S. FDA granted approval for Basaglar 100 units/mL. BASAGLAR is a long-acting...
Production & Manufacturing
Beximco Pharma forms JV with Malaysia-based BioCare Manufacturing
Beximco Pharmaceuticals Limited the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, announces the creation of a joint venture with BioCare Manufacturing...
News
Alcon spotlights DAILIES TOTAL1® contact lenses in national television campaign
TV spot showcases the science behind the ultimate breathability and comfort of DAILIES TOTAL1® contact lenses Fort Worth, Texas- Alcon, the...
News
Lilly to Present New Clinical Data at 75th American Diabetes Association® Scientific Sessions
New clinical data demonstrating the range of treatment options represented in Lilly's diabetes portfolio will be presented in 79 abstracts on June 5-9, at...
Press Releases
U.S. Food and Drug Administration Approves Humalog® 200 units/mL KwikPen®
The U.S. FDA has approved Humalog® 200 units/mL KwikPen, a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin. Humalog®...
Clinical Trials
FDA Approves Addition to CIALIS® (tadalafil) Product Label
Eli Lilly and Company announced the U.S. FDA approved a product label addition for CIALIS to include data from a 26-week study that showed...
Press Releases
Patheon® to Feature API Development and Manufacturing Capabilities at CPhI/ICSE Worldwide
Patheon is to showcase its biologic, small molecule API development services and manufacturing capabilities for finished dosage forms at CPhI / ICSE Worldwide from...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
